UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook

The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.

Buffett's 'Big Mistake' Is Finally Looking Up

Warren Buffett's big bet on kidney dialysis provider DaVita may finally be primed to start paying off, albeit after five frustrating years of negative returns.

Stalking an Entry in Regeneron Pharmaceuticals

A low-risk countertrend options trade may be worth a look in this name.

Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?

Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.

Walgreens Market Outlook, ePharmacy Acceleration Pummel Pharmacy Stocks

The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.

Is Opportunity Knocking as Walgreens Stock Suffers a Bloodletting?

Might this be the bottom? It might.

Walgreens Stock Falls After Earnings, Guidance Disappoint

Walgreens weak guidance is sending shares plummeting on Tuesday.

More Mud on Johnson & Johnson?

There's been enough news with the lawsuits around this name to get the emotion back into the stock. Emotion often leads to volatility.

Complexity Theory, Operation Un-Twist, Managed Care Stocks: Market Recon

It becomes difficult to own for anything other than a trade, managed care stocks and those that most benefit from Medicare expansion.

2 Recently Dinged Stocks Insiders Are Buying

A health and wellness provider and an amusement park operator have seen insider purchases amid declines in their shares.